Add Metropolis Healthcare, target price Rs 2,335: ICICI Securities

 13 Dec 2024 08:50 AM

ICICI Securities maintains an Add rating on Metropolis Healthcare with a raised target price of Rs 2,335. Metropolis is acquiring Core Diagnostics for Rs 2.47 billion, boosting its presence in the oncology market and expanding into North and Eastern India. This acquisition is projected to enhance Metropolis's growth and profitability over the long term.

2025 stocks ideas: Top 4 bets from IT, logistics space can give 11-30% returns

 12 Dec 2024 10:11 AM

Brokerages are bullish on select stocks, predicting growth in IT, logistics, auto, and healthcare. Metropolis Healthcare, Zen Technologies, VRL Logistics, and Hero MotoCorp are touted as potential winners, with projected returns ranging from 11% to a substantial 32% by 2025.

METROPOLIS HEALTHCARE: CO TO ACQUIRE 100% STAKE IN CORE DIAGNOSTICS FOR 2.47B RUPEES || ENTITY BEING ACQUIRED BELONGS TO DIAGNOSTIC SECTOR

 09 Dec 2024 05:40 PM

METROPOLIS HEALTHCARE: CO TO ACQUIRE 100% STAKE IN CORE DIAGNOSTICS FOR 2.47B RUPEES || ENTITY BEING ACQUIRED BELONGS TO DIAGNOSTIC SECTOR

METROPOLIS HEALTHCARE: CO TO CONSIDER PREFERENTIAL ISSUE OF EQUITY SHARES ON DEC 9

 05 Dec 2024 08:21 AM

METROPOLIS HEALTHCARE: CO TO CONSIDER PREFERENTIAL ISSUE OF EQUITY SHARES ON DEC 9

Stocks to Buy Today: Wipro, Syngene among top 6 trading ideas for 27 November 2024

 27 Nov 2024 09:06 AM

Indian markets are expected to trade higher on Wednesday, following positive global cues. Nifty futures closed 0.28% lower on Tuesday, with key support levels at 24,150 and 24,000. Experts recommend short-term buys in stocks like Wipro, City Union Bank, Kaynes, Metropolis Healthcare, Syngene, and BirlaSoft, with specified target prices and stop losses.

Asian Paints, Britannia among 5 stocks with short covering

 19 Nov 2024 03:19 PM

Short covering occurs when traders buy back shares, reducing open interest and boosting stock prices. Five stocks saw short covering on Tuesday, including Britannia, Metropolis Healthcare, and Asian Paints

METROPOLIS HEALTHCARE: Q2 EBITDA 899M RUPEES VS 748M (YOY) || Q2 EBITDA MARGIN 25.70% VS 24.25% (YOY)

 08 Nov 2024 06:10 PM

METROPOLIS HEALTHCARE: Q2 EBITDA 899M RUPEES VS 748M (YOY) || Q2 EBITDA MARGIN 25.70% VS 24.25% (YOY)

METROPOLIS HEALTHCARE: Q2 CONS NET PROFIT 465M RUPEES VS 354M (YOY); 379M (QOQ) || Q2 REVENUE 3.5B RUPEES VS 3.08B (YOY)

 08 Nov 2024 06:09 PM

METROPOLIS HEALTHCARE: Q2 CONS NET PROFIT 465M RUPEES VS 354M (YOY); 379M (QOQ) || Q2 REVENUE 3.5B RUPEES VS 3.08B (YOY)